Amgen (AMGN) Inventory (2009 - 2026)

Amgen's Inventory history runs 18 years deep, the most recent figure standing at $6.2 billion for Q1 2026.

• In Q1 2026, Inventory fell 8.07% year-over-year to $6.2 billion; the TTM figure through Mar 2026 stood at $6.2 billion (down 8.07% YoY), while the FY2025 annual figure was $6.2 billion, down 11.05% from the prior year.
• Inventory was $6.2 billion for Q1 2026 at Amgen, down from $6.2 billion in the prior quarter.
• In the past five years, Inventory ranged from a high of $9.5 billion in Q4 2023 to a low of $4.4 billion in Q1 2022.
• Historically, Inventory has averaged $6.3 billion across 5 years, with a median of $6.2 billion in 2025.
• The sharpest annual moves came in 2023 and 2024: Inventory jumped 93.06% in 2023, then declined 26.48% in 2024.
• A 5-year view of Inventory shows it stood at $4.9 billion in 2022, then surged by 93.06% to $9.5 billion in 2023, then slipped by 26.48% to $7.0 billion in 2024, then decreased by 11.05% to $6.2 billion in 2025, then retreated by 0.63% to $6.2 billion in 2026.
• The last three Inventory figures came in at $6.2 billion (Q1 2026), $6.2 billion (Q4 2025), and $6.3 billion (Q3 2025), per Business Quant data.